on 30 Aug 2017
Last Applicant/ Owned by
Celgene Corporation
86 Morris Avenue Summit NJ 07901
, ,
Serial Number
UK00801375613 filed on 30th Aug 2017
Registration Number
UK00801375613 registered on
18th Apr 2018
Correspondent Address
Rochester House, Eynsham Road, Farmoor
Oxford,
OX2 9NH
Pharmaceutical preparations for use in the treatment of cancer and immune related diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.
Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others; providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports.
Providing on-line information in the field of diagnosis and treatment of cancer; providing information relating to diagnosis and treatment of cancer, via an on-line computer database; providing medical information services; provision of information about the diagnosis and treatment of cancer, via websites; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries.
UK00801375613
Word
Individual